Aclaris Therapeutics

$27.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.50 (-5.18%) Today
$0.00 (0.00%) As of 8:41 PM UTC after-hours

Why Robinhood?

You can buy or sell ACRS and other stocks, options, and ETFs commission-free!

About ACRS

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments.

CEO
Neal S. Walker
Employees
60
Headquarters
Wayne, Pennsylvania
Founded
2012
Market Cap
1.42B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
900.47K
High Today
$28.79
Low Today
$27.10
Open Price
$28.76
Volume
570.62K
52 Week High
$30.38
52 Week Low
$1.02

ACRS Earnings

-$1.24
-$0.83
-$0.41
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market

You May Also Like

ARWR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure